First Time Loading...

Novo Nordisk A/S

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
Price: 906.1 DKK 2.15% Market Closed
Updated: Jul 21, 2024
Have any thoughts about
Novo Nordisk A/S?
Write Note

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on Jul 21, 2024.

Estimated DCF Value of one NOVO B stock is 687.64 DKK. Compared to the current market price of 906.1 DKK, the stock is Overvalued by 24%.

Base Case
687.64 DKK
Overvaluation 24%
DCF Value
Worst Case
Base Case
Best Case
DCF Value
Worst Case
Base Case
Best Case
DCF Value: 687.64 DKK

Present Value Calculation

This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.

DCF Model
Base Case Scenario

The present value of cash flows over the next 5 years amounts to 703.7B DKK. The present value of the terminal value is 2.4T DKK. The total present value equals 3.1T DKK.
Forecast Period
Discount Rate
Show All DCF Settings
Terminal Growth
Hide DCF Settings

DCF Value Calculation

This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.

Present Value to DCF Value
Capital Structure

Present Value 3.1T DKK
+ Cash & Equivalents 6.3B DKK
+ Investments 4.6B DKK
Firm Value 3.1T DKK
- Debt 16.8B DKK
Equity Value 3.1T DKK
/ Shares Outstanding 4.5B
NOVO B DCF Value 687.64 DKK
Overvalued by 24%

Valuation Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.

DCF Financials
Financials used in DCF Calculation

310.2B 563B
Operating Income
139.8B 261.6B
128.1B 212.8B

See Also

Discover More

What is the DCF value of one NOVO B stock?

Estimated DCF Value of one NOVO B stock is 687.64 DKK. Compared to the current market price of 906.1 DKK, the stock is Overvalued by 24%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Utilizing the DCF operating model, Novo Nordisk A/S's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at 3.1T DKK.

2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of 687.64 DKK per share.